Sionna Therapeutics Common Stock Performance

Sionna Therapeutics Relative Risk vs. Return Landscape

If you would invest  3,577  in Sionna Therapeutics Common on November 9, 2025 and sell it today you would earn a total of  34.00  from holding Sionna Therapeutics Common or generate 0.95% return on investment over 90 days. Sionna Therapeutics Common is currently generating 0.153% in daily expected returns and assumes 5.2553% risk (volatility on return distribution) over the 90 days horizon. In different words, 47% of stocks are less volatile than Sionna, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Sionna Therapeutics is expected to generate 6.42 times more return on investment than the market. However, the company is 6.42 times more volatile than its market benchmark. It trades about 0.03 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

Sionna Therapeutics Target Price Odds to finish over Current Price

Given the investment horizon of 90 days Sionna Therapeutics has a beta of 0.28. This usually implies as returns on the market go up, Sionna Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Sionna Therapeutics Common will be expected to be much smaller as well. Additionally Sionna Therapeutics Common has an alpha of 0.0985, implying that it can generate a 0.0985 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Sionna Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sionna Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 31.13 36.39 41.65 Details

Intrinsic Valuation Low Real High 33.15 38.41 43.67 Details

Naive Forecast Low Next High 29.06 34.32 39.57 Details

3 Analysts Consensus Low Target High 40.82 44.86 49.79 Details

Sionna Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Sionna Therapeutics is not an exception. The market had few large corrections towards the Sionna Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sionna Therapeutics Common, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sionna Therapeutics within the framework of very fundamental risk indicators.

Sionna Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sionna Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sionna Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Sionna Therapeutics Price Density Drivers

Sionna Therapeutics Fundamentals Growth

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sionna Therapeutics Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Investors evaluate Sionna Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Sionna Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Sionna Therapeutics' market price to deviate significantly from intrinsic value.

Please note, there is a significant difference between Sionna Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sionna Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Sionna Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.